5 completed, 2 recruiting, 2 unknown. 9 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 5, Recruiting 2, Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Corneal Ulcer: new trials by email Literature Review of Corneal Ulcer trials Research Report on Corneal Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A Cyclosporine A, Placebo Comparator: Placebo - Fungal Keratitis, Corneal Ulcer | Phase 3 | Recruiting | University of California, San Francisco | 150 | 2025-09-01 | 2026-06-05 |
| Parasitic Ulcer Treatment Trial Polyhexamethylene biguanide (PHMB), Topical corticosteroid, Topical placebo - Acanthamoeba Keratitis | Phase 3 | Recruiting | Jeremy Keenan, MD, MPH | 232 | 2024-07-01 | 2026-10-01 |
| Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial Tears - Keratitis, Corneal Ulcer | Phase 2 / Phase 3 | Unknown | Peschke GmbH | 488 | 2022-03-14 | 2022-10-28 |
| Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution, Standard of Care Therapy + Sham CXL + Artificial Tears - Keratitis, Corneal Ulcer | Phase 2 / Phase 3 | Unknown | Peschke GmbH | 468 | 2022-03-14 | 2022-10-28 |
| Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers Intrastromal voriconazole, Natamycin - Corneal Ulcer, Fungal Keratitis | Phase 3 | Completed | University of California, San Francisco | 70 | 2016-09-01 | 2025-09-25 |
| Cross-linking for Corneal Ulcers Treatment Trial Corneal Cross-linking, Anti Fungal Drug - Corneal Ulcer, Infectious Keratitis | Phase 3 | Completed | University of California, San Francisco | 147 | 2015-11-01 | 2025-06-18 |
| Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer T4020, Vehicle - Keratitis, Corneal Ulcer | Phase 3 | Completed | Laboratoires Thea | 152 | 2013-02-01 | 2019-10-23 |
| The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo Voriconazole, Placebo - Corneal Ulcer, Eye Infections, Fungal | Phase 3 | Completed | University of California, San Francisco | 240 | 2010-05-01 | 2019-02-26 |
| Mycotic Ulcer Treatment Trial I Natamycin, Voriconazole - Corneal Ulcer, Eye Infections, Fungal | Phase 3 | Completed | University of California, San Francisco | 323 | 2010-04-01 | 2018-08-01 |
Keratitis (4) · Corneal Diseases (2) · Eye Diseases (2) · Eye Infections, Fungal (2) · Mycoses (2) · Ulcer (2) · Acanthamoeba Keratitis (1)
Eye Infections (9) · Infections (9) · Corneal Diseases (7) · Eye Diseases (7) · Keratitis (5) · Bacterial Infections and Mycoses (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Amebiasis (1) · Eye Infections, Parasitic (1) · Parasitic Diseases (1) · Protozoan Infections (1)
Lubricant Eye Drops (2) · Natamycin (2) · Riboflavin (2) · Voriconazole (2) · Adrenal Cortex Hormones (1) · Corneal Cross-Linking (1) · Cyclosporine (1) · Pharmaceutical Vehicles (1) · polihexanide (1)
University of California, San Francisco (5) · Peschke GmbH (2) · Jeremy Keenan, MD, MPH (1) · Laboratoires Thea (1)
United States (8) · India (6) · Brazil (1) · France (1) · Nepal (1) · United Kingdom (1)
Bala Ambati (2) · NV Prajna, DNB, FRC Ophth (2) · Nisha Acharya, MD, MS (2) · Tom Lietman, MD (2) · Yvette Viscuso (2) · Gerami D Seitzman, MD (1) · Gerami Seitzman, MD (1) · Jennifer R Rose-Nussbaumer, MD (1) · Jennifer Rose-Nussbaumer, MD (1) · Jeremy Keenan, MD, MPH (1)
PMID 35024776, PMID 23702779, PMID 25764482, PMID 26531051, PMID 27054515, PMID 27787540, PMID 28426856, PMID 28817744, PMID 31619359, PMID 32557558, PMID 33031809, PMID 33079921, PMID 35044972, PMID 40372030
U10EY018573 (2), UG1EY033284 (1)